Assessment of a vaccinia virus vectored multi-epitope live vaccine candidate for Plasmodium falciparum

International Journal for Parasitology

Volumn 31, Issue 1, 2001, Pages 57-62

  Dong, Wenqi ^a   Li, Ming ^a   Bi, Huixiang ^a   Li, Yingjie ^a   Wu, Jun ^b   Qu, Lizhi ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Malaria; Plasmodium falciparum; Vaccine; Vaccinia virus

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G1; INTERFERON; INTERLEUKIN 1; LIVE VACCINE; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; PARASITE ANTIGEN; RECOMBINANT VACCINE; TETANUS TOXIN;

PARASITOLOGY; VACCINATION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CELL INTERACTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; GROWTH INHIBITION; HYBRID GENE; IMMUNE RESPONSE; IMMUNIZATION; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; RABBIT; RAT; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; IMMUNITY, CELLULAR; INTERFERONS; INTERLEUKIN-1; MALARIA VACCINES; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RABBITS; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; TETANUS TOXOID; VACCINIA VIRUS;

ANIMALIA; ORYCTOLAGUS CUNICULUS; PLASMODIUM FALCIPARUM; VACCINIA; VACCINIA VIRUS;

EID: 0035152971     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(00)00110-7     Document Type: Article

References (22)

1. A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity
2. Tell-subsets and cytokines in parasitic infections
3. Construction of a vaccinia virus vectored multi-epitope vaccine candidate for Plasmodium falciparum
4. Strategies for the development of an antimalarial vaccine
5. Adjuvants for human vaccine-current status, problems and future prospects
6. Reciprocal expression of interferin gamma or interleukin 4 during the resolution or progression of murine Leishmaniasis
7. Construction of vaccinia virus A-type inclusion body protein tandomly repeated mutant 7.5 kDa protein and hemagglutinin gene promotors support high level of expression
8. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein
9. Synchronization of Plasmodium falciparum erythrocytic stages in culture
10. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria
11. The inhibitory effects of immune sera against two recombinant hybrid antigens on the growth of P.f in vitro
12. Expression of hybrid genes of protective antigens of Plasmodium falciparum characterization of the expressed products
13. Rapid clorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay
14. A population-based clinical trails with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela
15. Induction of protective immunity against experimental infection with malaria using synthetic peptides
16. Immunity to malaria
17. Cell-mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparum
18. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens
19. Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus
20. NYVAC-Pf7: A poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria
21. Human malaria parasites in continuous culture
22. Vaccination with SPf66, a chemically synthesized vaccine, against Plasmodium falciparum in Columbia